200 related articles for article (PubMed ID: 8661391)
1. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1.
Morrison LA; Knipe DM
Virology; 1996 Jun; 220(2):402-13. PubMed ID: 8661391
[TBL] [Abstract][Full Text] [Related]
2. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
Morrison LA; Knipe DM
Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
4. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
Morrison LA; Knipe DM
J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
Da Costa XJ; Bourne N; Stanberry LR; Knipe DM
Virology; 1997 May; 232(1):1-12. PubMed ID: 9185583
[TBL] [Abstract][Full Text] [Related]
7. Biological properties of herpes simplex virus 2 replication-defective mutant strains in a murine nasal infection model.
Jones CA; Taylor TJ; Knipe DM
Virology; 2000 Dec; 278(1):137-50. PubMed ID: 11112490
[TBL] [Abstract][Full Text] [Related]
8. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
Mukerjee R; Kang W; Suri V; Fraser NW
Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
[TBL] [Abstract][Full Text] [Related]
9. Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice.
Jacobson JG; Chen SH; Cook WJ; Kramer MF; Coen DM
Virology; 1998 Mar; 242(1):161-9. PubMed ID: 9501052
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
Frye TD; Chiou HC; Hull BE; Bigley NJ
Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
[TBL] [Abstract][Full Text] [Related]
11. A replication competent HSV-1(McKrae) with a mutation in the amino-terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea infection.
Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
Curr Eye Res; 2014 Jun; 39(6):596-603. PubMed ID: 24401006
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection.
Ghiasi H; Cai S; Nesburn AB; Wechsler SL
Virology; 1996 Oct; 224(1):330-3. PubMed ID: 8862430
[TBL] [Abstract][Full Text] [Related]
13. Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease.
van Lint AL; Torres-Lopez E; Knipe DM
Virology; 2007 Nov; 368(2):227-31. PubMed ID: 17915278
[TBL] [Abstract][Full Text] [Related]
14. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.
Keadle TL; Morrison LA; Morris JL; Pepose JS; Stuart PM
J Virol; 2002 Apr; 76(8):3615-25. PubMed ID: 11907201
[TBL] [Abstract][Full Text] [Related]
16. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1.
Halford WP; Gebhardt BM; Carr DJ
J Immunol; 1996 Oct; 157(8):3542-9. PubMed ID: 8871654
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type 1 envelope subunit vaccine not only protects against lethal virus challenge, but also may restrict latency and virus reactivation.
Rajcáni J; Sabó A; Mucha V; Kostál M; Compel P
Acta Virol; 1995 Feb; 39(1):37-49. PubMed ID: 7572468
[TBL] [Abstract][Full Text] [Related]
18. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge.
Evans IA; Jones CA
J Infect Dis; 2002 Jun; 185(11):1550-60. PubMed ID: 12023760
[TBL] [Abstract][Full Text] [Related]
19. Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus.
Brubaker JO; Thompson CM; Morrison LA; Knipe DM; Siber GR; Finberg RW
J Immunol; 1996 Aug; 157(4):1598-604. PubMed ID: 8759744
[TBL] [Abstract][Full Text] [Related]
20. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
Ghiasi H; Perng G; Nesburn AB; Wechsler SL
Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
